[go: up one dir, main page]

GB201620758D0 - Novel process - Google Patents

Novel process

Info

Publication number
GB201620758D0
GB201620758D0 GBGB1620758.1A GB201620758A GB201620758D0 GB 201620758 D0 GB201620758 D0 GB 201620758D0 GB 201620758 A GB201620758 A GB 201620758A GB 201620758 D0 GB201620758 D0 GB 201620758D0
Authority
GB
United Kingdom
Prior art keywords
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1620758.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1620758.1A priority Critical patent/GB201620758D0/en
Publication of GB201620758D0 publication Critical patent/GB201620758D0/en
Priority to JP2019530148A priority patent/JP7136777B2/en
Priority to PCT/EP2017/081546 priority patent/WO2018104313A1/en
Priority to BE2017/5901A priority patent/BE1025160B1/en
Priority to BR112019011286-3A priority patent/BR112019011286A2/en
Priority to MX2019006728A priority patent/MX2019006728A/en
Priority to ES17828665T priority patent/ES2988600T3/en
Priority to US16/466,094 priority patent/US10695424B2/en
Priority to EP17828665.4A priority patent/EP3551222B1/en
Priority to CN201780074868.8A priority patent/CN110035770B/en
Priority to CA3045952A priority patent/CA3045952A1/en
Priority to ARP170103441A priority patent/AR110334A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GBGB1620758.1A 2016-12-07 2016-12-07 Novel process Ceased GB201620758D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1620758.1A GB201620758D0 (en) 2016-12-07 2016-12-07 Novel process
CA3045952A CA3045952A1 (en) 2016-12-07 2017-12-05 Novel process
BR112019011286-3A BR112019011286A2 (en) 2016-12-07 2017-12-05 methods for producing a liposome composition, for preparing a vaccine composition and for preparing a vaccine kit.
PCT/EP2017/081546 WO2018104313A1 (en) 2016-12-07 2017-12-05 Novel process
BE2017/5901A BE1025160B1 (en) 2016-12-07 2017-12-05 NEW PROCESS
JP2019530148A JP7136777B2 (en) 2016-12-07 2017-12-05 new process
MX2019006728A MX2019006728A (en) 2016-12-07 2017-12-05 Novel process.
ES17828665T ES2988600T3 (en) 2016-12-07 2017-12-05 Process for preparing a liposome composition comprising a saponin
US16/466,094 US10695424B2 (en) 2016-12-07 2017-12-05 Method of making a liposome composition
EP17828665.4A EP3551222B1 (en) 2016-12-07 2017-12-05 Process for making a liposome composition comprising a saponin
CN201780074868.8A CN110035770B (en) 2016-12-07 2017-12-05 New method
ARP170103441A AR110334A1 (en) 2016-12-07 2017-12-07 PROCEDURE FOR MANUFACTURING A LIPOSOMA COMPOSITION THAT INCLUDES A SAPONINE IN A SUBMYCHROMETRIC LIPOSOMIC FORMULATION IN WHICH LIPOSOMES CONTAIN A LIPID AND A STEROL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1620758.1A GB201620758D0 (en) 2016-12-07 2016-12-07 Novel process

Publications (1)

Publication Number Publication Date
GB201620758D0 true GB201620758D0 (en) 2017-01-18

Family

ID=58159667

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1620758.1A Ceased GB201620758D0 (en) 2016-12-07 2016-12-07 Novel process

Country Status (2)

Country Link
AR (1) AR110334A1 (en)
GB (1) GB201620758D0 (en)

Also Published As

Publication number Publication date
AR110334A1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
GB201609546D0 (en) Process
GB201605121D0 (en) Process
GB201615268D0 (en) Process
GB201609873D0 (en) Process
GB201615270D0 (en) Process
GB201600290D0 (en) Process
GB201618121D0 (en) Process
GB201714877D0 (en) Process
GB201602584D0 (en) Process
GB201617500D0 (en) Process
GB201716736D0 (en) Process
GB201602646D0 (en) Process
GB201600287D0 (en) Process
GB201620655D0 (en) Methanaol process
GB201620667D0 (en) Process
GB201610852D0 (en) Process
GB201613014D0 (en) Process
GB2548690B (en) Process
GB201620525D0 (en) Process
GB201610338D0 (en) Process
GB201617561D0 (en) Process
GB201701903D0 (en) Process
GB201609545D0 (en) Process
GB201608243D0 (en) Process
GB201721495D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)